Literature DB >> 11576548

Inhibition of Src by direct interaction with protein phosphatase 2A.

N Yokoyama1, W T Miller.   

Abstract

In this study, we report that Src kinase is inhibited by protein phosphatase 2A (PP2A), a serine/threonine phosphatase. We carried out experiments in vitro using purified PP2A (AC dimer) and full-length v-Src or truncated forms of v-Src. The inhibition of v-Src by PP2A is concentration- and time-dependent. Addition of okadaic acid, a PP2A phosphatase inhibitor, abolished the PP2A-dependent inhibition of v-Src. When experiments were carried out at 4 degrees C under conditions where PP2A activity is inhibited, Src activity was unaffected by the presence of PP2A, suggesting that PP2A binding alone is insufficient to block Src activity. These results imply that PP2A activity is essential for inhibition of v-Src. We also demonstrate that PP2A binds to the catalytic and the regulatory domains of v-Src.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11576548     DOI: 10.1016/s0014-5793(01)02874-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Cross-talk between serine/threonine protein phosphatase 2A and protein tyrosine phosphatase 1B regulates Src activation and adhesion of integrin αIIbβ3 to fibrinogen.

Authors:  Subhashree Pradhan; Nawaf Alrehani; Vimal Patel; Tanvir Khatlani; K Vinod Vijayan
Journal:  J Biol Chem       Date:  2010-07-08       Impact factor: 5.157

Review 2.  Protein Phosphatase 2A: a Double-Faced Phosphatase of Cellular System and Its Role in Neurodegenerative Disorders.

Authors:  Md Nematullah; M N Hoda; Farah Khan
Journal:  Mol Neurobiol       Date:  2017-02-21       Impact factor: 5.590

3.  Critical role of Casein kinase 2 in hepatitis C NS5A-mediated inhibition of Kv2.1 K(+) channel function.

Authors:  Katerina Clemens; Chung-Yang Yeh; Elias Aizenman
Journal:  Neurosci Lett       Date:  2015-10-17       Impact factor: 3.046

4.  A RNA interference screen identifies the protein phosphatase 2A subunit PR55gamma as a stress-sensitive inhibitor of c-SRC.

Authors:  Pieter J A Eichhorn; Menno P Creyghton; Kevin Wilhelmsen; Hans van Dam; René Bernards
Journal:  PLoS Genet       Date:  2007-12       Impact factor: 5.917

Review 5.  ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.

Authors:  D Perrotti; P Neviani
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

6.  Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis and APP regulation.

Authors:  Goce Taleski; Diana Schuhmacher; Henry Su; Jean-Marie Sontag; Estelle Sontag
Journal:  J Biol Chem       Date:  2020-12-30       Impact factor: 5.157

7.  Microcystin-LR incorporated into colonic cells through probenecid-sensitive transporters leads to upregulated MCP-1 expression induced by JNK activation.

Authors:  Yoshihito Koto; Hideaki Kawahara; Koichi Kurata; Keisuke Yoshikiyo; Ayumi Hashiguchi; Kunihiro Okano; Norio Sugiura; Kazuya Shimizu; Hidehisa Shimizu
Journal:  Toxicol Rep       Date:  2022-04-20

8.  Pharmacological evidence for altered src kinase regulation of I (Ca,L) in patients with chronic atrial fibrillation.

Authors:  Maura Greiser; Christian R Halaszovich; Dirk Frechen; Peter Boknik; Ursula Ravens; Dobromir Dobrev; Andreas Lückhoff; Ulrich Schotten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-26       Impact factor: 3.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.